Alzheimer's Disease Trial, Recruiting NCT06953167 Sponsor: Imperial College London Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06953167
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female and are over 65 years of age.
  • People who are willing and mentally able to give written consent to take part, OR — if someone is not able to make that decision for themselves — they have a nominated representative (called a "consultee") who can confirm that taking part is what the person would have wanted.
  • People who have already completed a specific type of brain screening test for amyloid (a protein linked to memory conditions), either through a brain scan (PET scan) or a fluid sample taken from around the spine (CSF test).
  • People who are fluent in English and able to read and write in English, and who have adequate hearing and vision to complete the memory and thinking tests required by the study.
  • People who are willing and able to attend all required study visits and follow the study procedures.
  • People who have a trusted person in their life — such as a family member, partner, or close friend — who is over 18, fluent in English, able to give their own consent to assist with the study, and who has enough regular contact with the participant (at least twice a month, in person or by phone/video) to provide meaningful information about the participant's day-to-day functioning. This person must attend the first study visit in person, but may be able to take part remotely after that.

Who may not be able to join:

  • People with a disability or condition that would prevent them from completing the study procedures or tests — for example, significant vision or hearing problems, speech difficulties, or physical or sensory impairments — or anyone whose participation the study doctor believes would not be in their best interest or would interfere with the study results.
  • People who would be unable to meet the specific requirements of the study.
  • People who have had a diagnosis of alcohol or drug dependence or misuse within the last 3 years, based on current medical diagnostic criteria.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 March 2025
Est. completion
1 February 2029

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Change from baseline in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Index scores; Change from baseline in the Preclinical Alzheimer Cognitive Composite (PACC) component scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov